Skip to main content

Year: 2024

iCoreConnect Partners With The Dental Marshal to Bring Cloud Software Solutions to Client Dentists

OCOEE, Fla., Dec. 16, 2024 (GLOBE NEWSWIRE) — iCoreConnect Inc. (NASDAQ: ICCT), a leading provider of cloud-based software and technology solutions, has announced a new Channel Partner agreement with The Dental Marshal, an expert consulting service for dental practice organizations and workplace optimization. The Dental Marshal specializes in facility and supply organization, effective employee delegation, and streamlined workflow management processes. With this partnership, The Dental Marshal can further empower its customers by providing iCoreConnect’s cloud-based Software-as-a-Service (SaaS) and technology solutions:iCoreRx – Cloud ePrescribing + Electronic Prescribing for Controlled Substances (EPCS) iCoreVerify – Automated Insurance Verification iCoreVerifyPro – Full-Service Verifications iCorePay – Digital Patient Statements,...

Continue reading

Upstream Bio Announces Addition to Russell 2000® Index

WALTHAM, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) — Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that the Company will be added to the Russell 2000® index as part of the planned fourth quarter initial public offering (IPO) additions effective at the open of the U.S. equity markets on December 23, 2024.   Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of December 2023, about $10.5 trillion in assets are benchmarked against the Russell US indexes, which belong to FTSE Russell, a prominent global index provider. The Russell 2000® Index measures the performance of the...

Continue reading

NV5 Awarded $10 Million in Critical Mineral Geospatial Projects by U.S. Geological Survey

HOLLYWOOD, Fla., Dec. 16, 2024 (GLOBE NEWSWIRE) — NV5, a provider of technology, certification, and consulting solutions, announced today that it has been awarded $10 million in contracts by the U.S. Geological Survey (USGS) to provide high-precision geospatial services to support essential geological research across multiple regions. These contracts will provide USGS with the critical data needed to advance the Earth Mapping Resources Initiative (Earth MRI) program, supporting the identification and management of critical minerals in the United States. Demand for critical minerals is growing to support the energy independence transition, and identification of domestic sources reduces dependence on international suppliers. “The increasing importance of geospatial data in supporting vital mineral exploration highlights the growing...

Continue reading

Daré Bioscience Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder (FSAD)

FSAD is clinically analogous to erectile dysfunction in men.To date, there are no FDA-approved pharmacological treatments for FSAD; Daré’s Sildenafil Cream has the potential to receive the first FDA approval for FSAD. Market research estimates approximately 10 million women in the U.S. are distressed from experiencing symptoms associated with FSAD and are actively seeking solutions to improve their condition. SAN DIEGO, Dec. 16, 2024 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, and its collaborator Strategic Science & Technologies, LLC (SST), a Cambridge, MA based novel topical drug delivery company, today announced plans for a Phase 3 study of Sildenafil Cream, 3.6%, an investigational topical cream formulation of sildenafil being developed as an on-demand...

Continue reading

AFEELA Introduces Stingray Karaoke as its In-Car Entertainment Service

MONTREAL, Dec. 16, 2024 (GLOBE NEWSWIRE) — Sony Honda Mobility Inc. (SHM) announced today that they have partnered with Stingray Group Inc. (TSX: RAY.A; RAY.B), a leading music, media and technology company, to expand its in-car entertainment services. Through this partnership, AFEELA customers will be able to use Stingray Karaoke and enjoy in-car karaoke services. With the introduction of Stingray Karaoke, customers will have access to a massive international song library of over 100,000 licensed tracks. This collection browsable by title, artist, lyrics, or genre, features today’s top charting artists and yesterday’s legends. It spans a wide range of genres, including Pop, Rock, Country, Rap, R&B, K-Pop, Holiday Classics and Kids & Family, providing AFEELA customers with an enhanced entertainment experience for every...

Continue reading

Forian Partners With Databricks to Expand Access to Advanced Healthcare Analytics

NEWTOWN, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) — Forian Inc. (Nasdaq: FORA), a leading provider of data science driven information and analytics solutions to the life science, healthcare and financial services industries, today announced a partnership with Databricks, the data and AI company, to deliver access to its Chartis™ product, which maps physician and organization affiliations, through Databricks Marketplace. This collaboration will empower healthcare organizations with enhanced visibility into Forian’s robust information products, driving innovative solutions in healthcare research, drug development and patient care. Using Forian’s proprietary scoring algorithm, Chartis™ is designed to uncover and track valuable provider connections to enhance decision-making across the healthcare ecosystem. Employing an innovative...

Continue reading

LGI Homes Opens New Community in Pennsylvania

The Franklin by LGI HomesThe Franklin features a spacious, open-concept layout floor plan and beautiful exterior stone detailing.WAYNESBORO, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGI Homes, Inc. (NASDAQ: LGIH) is excited to announce the grand opening of Brimington Farm, a brand-new community in Waynesboro, Pennsylvania. This affordable, upgraded community offers homebuyers the opportunity to purchase a newly built home with built-in upgrades at a price that makes homeownership attainable. Brimington Farm offers modern homes in a charming, established neighborhood. Homebuyers can choose from 3-bedroom townhomes starting in the $300s or 3- to 4-bedroom single-family homes starting in the mid-$400s. Each home comes with LGI Homes’ CompleteHome Plus™ package, including granite countertops,...

Continue reading

Accolade to Announce Fiscal Third Quarter 2025 Financial Results

SEATTLE, Dec. 16, 2024 (GLOBE NEWSWIRE) — Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal third quarter 2025 financial results on Thursday, January 9, 2024 after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details To Listen via Telephone: Pre-registration is required by the conference call operator. Please pre-register by clicking here. (https://register.vevent.com/register/BI0dce2f02ed2f44c8901127623aa788c3) Upon registering, you will be emailed a dial-in number, direct passcode and unique PIN. To Listen via Internet: The conference call can be accessed via a live audio webcast that will be available online at http://ir.accolade.com . Replay: A replay of the call will be available for one year via webcast...

Continue reading

Greenridge Exploration Pinpoints High Priority Uranium Targets with KorrAI’s Advanced Analysis at its Nut Lake Project

VANCOUVER, British Columbia, Dec. 16, 2024 (GLOBE NEWSWIRE) — Greenridge Exploration Inc. (“Greenridge” or the “Company”) (CSE: GXP | OTC: GXPLF | FRA: HW3), is pleased to announce the successful implementation of KorrAI Technologies Inc.’s (“KorrAI“) advanced analysis at the Company’s Nut Lake Project (the “Project“). KorrAI’s hyperspectral imaging and AI-driven analysis continue to play a critical role in enhancing the efficiency and precision of future exploration efforts, leading to actionable targets and advancing Greenridge’s objectives. The Company received significant outcomes, which were achieved through this innovative program with KorrAI (the “Program“). The 2024 exploration program included seventeen (17) sample locations that showed readings greater than 30,000 cps, with...

Continue reading

BioAtla Presented Data Characterizing Mutated KRAS Genotype and Clinical Outcomes in Patients with Advanced NSCLC Treated with Mecbotamab Vedotin (Mec-V), a CAB-AXL-ADC, at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting

Improved median overall survival (OS) for Mec-V treated patients with treatment-refractory non-small cell lung cancer (NSCLC) expressing mutated KRAS (mKRAS) as compared to Mec-V treated patient with treatment-refractory NSCLC expressing wild-type KRAS (wtKRAS) One-year OS was 58% for patients with NSCLC expressing mKRAS versus 23% for wtKRAS Mec-V antitumor activity observed across 9 different mKRAS variants Strong association of AXL expression by mKRAS NSCLC confirmed SAN DIEGO, Dec. 16, 2024 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, presented a poster entitled “Characterization of Mutated KRAS Genotype and Clinical Outcomes in Patients With Advanced NSCLC...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.